Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance. This funding opportunity supports research that combines advanced imaging techniques with liquid biopsy methods to better understand cancer treatment effectiveness and the development of treatment resistance in patients undergoing therapy. The program aims to optimize the use of these complementary monitoring approaches to improve cancer care outcomes.